www.beactica.se Open in urlscan Pro
217.70.37.6  Public Scan

Form analysis
2 forms found in the DOM

/search-results

<form action="/search-results">
  <input type="text" name="q" placeholder="Search...">
  <input type="submit">
</form>

POST

<form method="post">
  <input class="formcaptcha2" name="__email verification 2" type="text">
  <input type="email" name="email" placeholder="Email address..." required="">
  <button type="submit" data-val="Skicka" name="newsletter" value="Sign Up">Sign up</button>
  <input name="__RequestVerificationToken" type="hidden" value="CfDJ8Kjb6DLlXXBCsEmgF_ydCPaouMu1_bZFdoxuO1OU9EjGpI8NtZSFIHoG7FAigxZLYvuuf6vpASpCMq1xHBFV9Nn0du1n-idZA5KjG02yV4zSTIwWrKpQe5VimDLtqLp4nINzA6wRNOuEnq2hgg_JxUs">
</form>

Text Content

 * 
 * 


 * 
 * About us Öppna
   * Our Background
   * Our Vision and Culture
   * Our Team
   * Careers
 * Science Öppna
   * Pipeline
   * Synthetic Lethality
   * Targeted Protein Degradation
   * Platform Success
   * Scientific Publications
 * Investors Öppna
   * Overview
 * Partnering Öppna
   * Drug Discovery Partnerships
   * Research Consortia
   * Services
   * Events
 * Resources & Media Öppna
   * Press Releases
   * Events
   * Recent Coverage
   * Videos
 * Contact




COMMITTED TO THE FIGHT AGAINST CANCER

Beactica Therapeutics is a precision oncology company developing novel,
life-saving small molecule therapeutics to treat genetically defined cancers
with significant unmet clinical need.

Explore more
Latest Press


BEACTICA THERAPEUTICS’ TEAD PROGRAMME SELECTED FOR LATE-BREAKING RESEARCH
PRESENTATION...

14 Feb 2024

Read more
Latest Publication


DEGRADERS OF TEAD TRANSCRIPTION FACTORS BASED ON INTERFACE 3 BINDERS

07 Apr 2024

Read more
Latest Event


BIO-EUROPE 2024

04 Nov 2024

Read more


"BEACTICA HAS A RICH AND UNIQUE HISTORY OF CREATING IMPACT AND HAS ALWAYS BEEN
DEDICATED TO EXCELLENCE AND INNOVATION. WE USE OUR PASSION FOR SCIENCE COMBINED
WITH THE EXCEPTIONAL SKILLS, EXPERTISE AND SCIENTIFIC KNOWLEDGE OF OUR TEAM TO
DISCOVER AND DEVELOP NOVEL CANCER THERAPEUTICS AND MAKE A DIFFERENCE WHERE IT
REALLY MATTERS."

- Per Källblad Ph.D. Chief Executive Officer

Learn More


A GROWING PIPELINE OF NOVEL THERAPEUTICS

Inspired by the possibility of improving the prospects for patients living with
life-threatening conditions, we are setting the pace for years to come in the
continuously evolving cancer drug development landscape. Our growing team of
future-thinking scientists and development professionals are driving the
advancement of multiple life-saving therapeutics into the clinic to get them to
the patients that need them.

Learn More


MAXIMISING CLINICAL GAINS WITH SYNTHETIC LETHALITY

With a clear vision and focus, we are leveraging synthetic lethality
vulnerabilities to meticulously develop breakthrough solutions that specifically
and effectively target genetically defined cancers.

Learn More


OFFERING COMPELLING INVESTMENT OPPORTUNITIES

With support from purposeful, mutually beneficial investments, we deliver value
to patients and stakeholders. Our historic success in lead generation using our
partner-validated drug development technology offers a secure foundation for the
growth and advancement of our proprietary novel therapeutics to be progressed
into the clinic.

Learn More


STAY UPDATED

Sign up for the Beactica newsletter to receive our latest news and updates

Sign up

Beactica Therapeutics AB Uppsala Business Park Rapsgatan 7 754 50 Uppsala Sweden

+46 (0)18 56 08 80

 * 
 * About us Öppna
   * Our Background
   * Our Vision and Culture
   * Our Team
   * Careers
 * Science Öppna
   * Pipeline
   * Synthetic Lethality
   * Targeted Protein Degradation
   * Platform Success
   * Scientific Publications
 * Investors Öppna
   * Overview
 * Partnering Öppna
   * Drug Discovery Partnerships
   * Research Consortia
   * Services
   * Events
 * Resources & Media Öppna
   * Press Releases
   * Events
   * Recent Coverage
   * Videos
 * Contact


QUESTIONS?

Feel free to get in touch with your questions about our drug pipeline, unique
technology or company developments using our online form. Keep up to date with
our latest news through following our social media accounts.

Get in touch
 * 
 * 

© 2024 - Beactica Therapeutics AB

 * Policy

This website uses cookies to improve your user experience. By continuing to
browse this site, you agree to our use of cookies. More information Ok